Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Pharmacol Ther. 2008 Jun 13;120(1):1–34. doi: 10.1016/j.pharmthera.2008.05.005

Figure 12.

Figure 12

Activities (in blue) are hypothesis driven and attempt to identify biomarkers based on the disequilibrium of identified targets in diabetic neuropathy, leading to an abnormal accumulation of products, such as modified proteins or small molecules. Activities in red are discovery oriented and seek to identify features of the data set that are predictive of diabetic neuropathy without necessarily corresponding to a single target.